Posts Tagged ‘Apotex; Arrow; merger’

Melbourne, September 20, 2018 – The Australian Competition and Consumer Commission (ACCC) announced this morning that it ‘has decided not to oppose the merger of generic pharmaceutical companies, Arrow and Apotex’ after finding the transaction would not substantially lessen competition in any market. In May 2018, Strides Pharma Science Ltd and Apotex Inc. announced their…